Amexdrug Statistics

Total Valuation

Amexdrug has a market cap or net worth of 16,911.

Market Cap	16,911
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Amexdrug has 169.11 million shares outstanding.

Current Share Class	169.11M
Shares Outstanding	169.11M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 0.10.

PE Ratio	0.10
Forward PE	n/a
PS Ratio	0.00
PB Ratio	0.03
P/TBV Ratio	0.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 1.46.

Current Ratio	1.35
Quick Ratio	0.67
Debt / Equity	1.46
Debt / EBITDA	2.52
Debt / FCF	-1.79
Interest Coverage	6.93

Financial Efficiency

Return on equity (ROE) is 28.78% and return on invested capital (ROIC) is 16.75%.

Return on Equity (ROE)	28.78%
Return on Assets (ROA)	11.25%
Return on Invested Capital (ROIC)	16.75%
Return on Capital Employed (ROCE)	34.43%
Revenue Per Employee	833,411
Profits Per Employee	15,076
Employee Count	11
Asset Turnover	4.99
Inventory Turnover	11.76

Taxes

In the past 12 months, Amexdrug has paid 120,227 in taxes.

Income Tax	120,227
Effective Tax Rate	42.03%

Stock Price Statistics

The stock price has decreased by -95.24% in the last 52 weeks. The beta is -0.22, so Amexdrug's price volatility has been lower than the market average.

Beta (5Y)	-0.22
52-Week Price Change	-95.24%
50-Day Moving Average	0.12
200-Day Moving Average	0.11
Relative Strength Index (RSI)	32.63
Average Volume (20 Days)	2,911

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Amexdrug had revenue of 9.17 million and earned 165,834 in profits. Earnings per share was 0.00.

Revenue	9.17M
Gross Profit	1.27M
Operating Income	330,933
Pretax Income	286,061
Net Income	165,834
EBITDA	380,827
EBIT	330,933
Earnings Per Share (EPS)	0.00

Full Income Statement

Balance Sheet

The company has 168,009 in cash and 961,115 in debt, giving a net cash position of -793,106 or -0.00 per share.

Cash & Cash Equivalents	168,009
Total Debt	961,115
Net Cash	-793,106
Net Cash Per Share	-0.00
Equity (Book Value)	658,233
Book Value Per Share	0.00
Working Capital	456,846

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -74,833 and capital expenditures -460,984, giving a free cash flow of -535,817.

Operating Cash Flow	-74,833
Capital Expenditures	-460,984
Free Cash Flow	-535,817
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 13.80%, with operating and profit margins of 3.61% and 1.81%.

Gross Margin	13.80%
Operating Margin	3.61%
Pretax Margin	3.12%
Profit Margin	1.81%
EBITDA Margin	4.15%
EBIT Margin	3.61%
FCF Margin	n/a

Dividends & Yields

Amexdrug does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	980.63%
FCF Yield	-3,168.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 3, 2012. It was a forward split with a ratio of 20.

Last Split Date	Dec 3, 2012
Split Type	Forward
Split Ratio	20

Scores

Amexdrug has an Altman Z-Score of 23.07 and a Piotroski F-Score of 3.

Altman Z-Score	23.07
Piotroski F-Score	3